CD8A and neoplasm: In vivo, caerin 1.1/1.9 suppresses the growth of HPV-positive TC-1 tumors, recruits more CD8+ T cells and NK cells to the tumor site [27], and modulates macrophage polarization by shifting M2 macrophages to the M1 phenotype [28].